Nevertheless, they showed a trend toward higher-than-expected reporting rates.
← all excerpts
Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review.
1
—
—
Nevertheless, they showed a trend toward higher-than-expected reporting rates.